Immune checkpoint inhibitors in pediatric central nervous system tumors: biology, clinical experience, and translational pathways to precision immunotherapy.
Saved in:
| Title: | Immune checkpoint inhibitors in pediatric central nervous system tumors: biology, clinical experience, and translational pathways to precision immunotherapy. |
|---|---|
| Authors: | Yenidogan I; Division of Hematology/Oncology, The Hospital for Sick Children, Room 10-14-049, 175 Elizabeth St, Toronto, ON M5G 2G3, Canada., Tabori U; Division of Hematology/Oncology, The Hospital for Sick Children, Room 10-14-049, 175 Elizabeth St, Toronto, ON M5G 2G3, Canada.; The Arthur and Sonia Labbatt Brain Tumor Research Center, Toronto, Canada.; Department of Paediatrics, University of Toronto, Toronto, Canada., Das A; Division of Hematology/Oncology, The Hospital for Sick Children, Room 10-14-049, 175 Elizabeth St, Toronto, ON M5G 2G3, Canada. anirban.das@sickkids.ca.; The Arthur and Sonia Labbatt Brain Tumor Research Center, Toronto, Canada. anirban.das@sickkids.ca.; Department of Paediatrics, University of Toronto, Toronto, Canada. anirban.das@sickkids.ca. |
| Source: | Journal of neuro-oncology [J Neurooncol] 2026 Mar 02; Vol. 177 (1). Date of Electronic Publication: 2026 Mar 02. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 8309335 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-7373 (Electronic) Linking ISSN: 0167594X NLM ISO Abbreviation: J Neurooncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
